Acousort AB (ACOUS)

Currency in SEK
4.0300
0.0000(0.00%)
Real-time Data·
Advertisement
ACOUS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.03004.0300
52 wk Range
2.03005.1600
Key Statistics
Prev. Close
4.01
Open
4.03
Day's Range
4.03-4.03
52 wk Range
2.03-5.16
Volume
194
Average Volume (3m)
42.42K
1-Year Change
18.5294%
Book Value / Share
0.65
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACOUS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
27/05/2026
EPS / Forecast
-0.11 / --
Revenue / Forecast
2.1M / 2.4M
EPS Revisions
Last 90 days

Compare ACOUS to Peers and Sector

Metrics to compare
ACOUS
Peers
Sector
Relationship
P/E Ratio
−8.0x−12.5x−0.4x
PEG Ratio
−0.16−0.290.00
Price/Book
6.1x5.1x2.6x
Price / LTM Sales
8.3x17.0x3.0x
Upside (Analyst Target)
178.5%153.1%57.3%
Fair Value Upside
Unlock−10.0%8.9%Unlock

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a microfluidic cell sorters or quality control systems for bioreactors and cell therapy production; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has a collaboration agreement with Moeller Medical to exhibit a prototype system for analyzing separation of cells from body fluids. AcouSort AB (publ) was incorporated in 2010 and is based in Lund, Sweden.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
4.63M21.86%18.64M
Public Companies & Retail Investors
16.54M78.14%66.65M
Total
21.16M100.00%85.29M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Avanza Fonder AB12.84%2,717,43510,951
Freltec ApS4.66%985,7893,973

FAQ

What Is the Acousort (Stockholm: ACOUS) Share Price Today?

The Acousort stock price today is 4.0300 SEK.

What Stock Exchange Does Acousort (ACOUS) Trade On?

Acousort is listed and trades on the Stockholm Stock Exchange.

What Is the Ticker (Stock Symbol) for Acousort?

The stock symbol (also called a 'ticker') for Acousort is "ACOUS."

What Is the Current Acousort Market Capitalisation?

As of today, Acousort (Stockholm: ACOUS) market cap is 85.2900M SEK.

What Is Acousort's (ACOUS) Earnings Per Share (TTM)?

The Acousort EPS is currently -0.5143 (Trailing Twelve Months).

When Is the Next Acousort Earnings Date?

Acousort's next earnings report will be released on 26/08/2026.

Is ACOUS a Buy or Sell From a Technical Analyst Perspective?

Based on today's Acousort moving averages and other technical indicators, the daily buy/sell signal for ACOUS stock is Sell.

How Many Times Has Acousort Stock Split?

Acousort has split 0 times. (See the ACOUS stock split history page for full effective split date and price information.)

How Many Employees Does Acousort Have?

Acousort has 11 employees, based on their latest Companies House report.

What is the current trading status of Acousort (Stockholm: ACOUS)?

As of 24/06/2026, Acousort (ACOUS) is trading at a share price of 4.0300 SEK, with a previous close of 4.0100 SEK. The stock has fluctuated within a day range of 4.0300 SEK to 4.0300 SEK, while its 52-week range spans from 2.0300 SEK to 5.1600 SEK.

What Is Acousort (ACOUS) Price Target According to Analysts?

The average 12-month price target for Acousort is 11.0000 SEK, with a high estimate of 11 SEK and a low estimate of 11 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +172.95% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.